A Study of Bortezomib as Consolidation Therapy in Patients With Multiple Myeloma
Clinical trial NCT00416273 · COMPLETED
Trial details
- NCT number
- NCT00416273
- Sponsor
- Janssen-Cilag G.m.b.H
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2013-05-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.